Exelixis Inc

XNAS:EXEL

50.48

-0.97 (-1.88%)

7:59:54 PM EDT: $50.85 +0.37 (+0.73%)

Market Cap (Intraday)	12.45B
Current PE	14.94
Forward PE	14.46
2yr Forward PE	12.84

See more stats

Estimates Current Quarter

Revenue	$632.5 Million
Adjusted EPS	$0.84

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Exelixis Inc Stock, XNAS:EXEL

1851 Harbor Bay Parkway, Alameda, California 94502

United States of America

Phone: +1.650.837.7000

Number of Employees: 1147

http://www.exelixis.com

Description

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.